Last reviewed · How we verify
Phenlarmide Tablets
At a glance
| Generic name | Phenlarmide Tablets |
|---|---|
| Also known as | FLZ |
| Sponsor | Yiling Pharmaceutical Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets (PHASE1)
- A Clinical Study Trial of Phenlarmide in China (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phenlarmide Tablets CI brief — competitive landscape report
- Phenlarmide Tablets updates RSS · CI watch RSS
- Yiling Pharmaceutical Inc. portfolio CI